Success Stories

Event Videos

The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease https://www.ncbi.nlm.nih.gov/pubmed/29517271 Biomark Med. 2018 Mar;12(3):265-273. doi: 10.2217/bmm-2017-0038. Epub 2018 Mar 8. The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease. Mandelia C, Kabbany MN, Conjeevaram Selvakumar PK, Alkhouri N. Abstract Published on: Mar-2018 Read more	Diagnostic Performance of MR Elastography for Liver Fibrosis in Children and Young Adults with a Spectrum of Liver Diseases https://www.ncbi.nlm.nih.gov/pubmed/29470938 Radiology. 2018 Feb 22:172099. doi: 10.1148/radiol.2018172099. [Epub ahead of print]. Trout AT, Sheridan RM, Serai SD, Xanthakos SA, Su W, Zhang B, Wallihan DB. Abstract Published on: Feb-2018 Read more
Evolving Practice and Changing Phenotype in Pediatric Autoimmune LiverDisease: Outcomes From an Australian Center https://www.ncbi.nlm.nih.gov/pubmed/29470284 Autoimmune hepatitis J Pediatr Gastroenterol Nutr. 2018 Feb 21. doi: 10.1097/MPG.0000000000001927. [Epub ahead of print].Singh H, Balouch F, Noble C, Lewindon P. Abstract OBJECTIVES: Autoimmune liver disease (AILD) incorporates primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH), and autoimmune sclerosing cholangitis (ASC). ASC is a condition that includes overlap of AIH and PSC. We investigate changes in practice in relation to diagnosis and phenotype over 2 time periods. METHODS: Retrospective chart review was conducted from January 2000 to 2016. Data were divided into two 8-year cohorts, CI and C2. RESULTS: Published on: Feb-2018 Read more	Pediatric Fatty Liver Disease (PeFLD): all is not NAFLD - pathophysiological insights and approach to management https://www.ncbi.nlm.nih.gov/pubmed/29471012 NAFLD J Hepatol. 2018 Feb 19. pii: S0168-8278(18)30123-5. doi: 10.1016/j.jhep.2018.02.006. [Epub ahead of print] .Hegarty R, Deheragoda M, Fitzpatrick E, Dhawan A. Abstract Published on: Feb-2018 Read more
Genetic Variants Associated With Obesity and Insulin Resistance in Hispanic Boys With Nonalcoholic Fatty Liver Disease https://www.ncbi.nlm.nih.gov/pubmed/29470286 NAFLD J Pediatr Gastroenterol Nutr. 2018 Feb 21. doi: 10.1097/MPG.0000000000001926. [Epub ahead of print] Rausch JC, Lavine JE, Chalasani N, Guo X, Kwon S, Schwimmer JB, Molleston JP, Loomba R, Brunt EM, Chen YI, Goodarzi MO, Taylor KD, Yates KP, Rotter JI; NASH Clinical Research Network. Abstract BACKGROUND AND OBJECTIVES: Published on: Feb-2018 Read more	Nonalcoholic Fatty Liver Disease in Children https://www.ncbi.nlm.nih.gov/pubmed/29471561 NAFLD Semin Liver Dis. 2018 Feb;38(1):1-13. doi: 10.1055/s-0038-1627456. Epub 2018 Feb 22.. Mann JP, Valenti L, Scorletti E, Byrne CD, Nobili V. Abstract Published on: Feb-2018 Read more
Autoimmune Hepatitis in Children and Adolescents: Effect on Quality of Life https://www.ncbi.nlm.nih.gov/pubmed/29470290 Autoimmune hepatitis J Pediatr Gastroenterol Nutr. 2018 Feb 21. doi: 10.1097/MPG.0000000000001930. [Epub ahead of print] Trevizoli IC, Pinedo CS, Teles VO, Seixas RBPM , de Carvalho E. Abstract OBJECTIVES: The aim of the to evaluate the effect of autoimmune hepatitis (AIH) on the quality of life of children and adolescents and to identify which variables effect health-related quality of life (HRQoL). METHODS: The Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0) was used to evaluate HRQoL. In addition, a questionnaire was applied which included signs, symptoms, and use of medications. RESULTS: Published on: Feb-2018 Read more	Improvement of life quality measured by Lansky Score after enzymatic replacement therapy in children with Gaucher disease type 1 https://www.ncbi.nlm.nih.gov/pubmed/29471591 Gauchers Mol Genet Genomic Med. 2018 Jan;6(1):27-34. doi: 10.1002/mgg3.339. Epub 2017 Oct 25.. Cerón-Rodríguez M, Barajas-Colón E, Ramírez-Devars L, Gutiérrez-Camacho C, Salgado-Loza JL. Abstract BACKGROUND: Gaucher disease type 1 (GD1, OMIM# 230800), is a condition with high impact in patient's quality of life (QoL). We report the improvement in QoL of children with GD1 measured by Lansky play-performance scale (LS) after enzymatic replacement therapy (ERT) and to describe our experience in the treatment of children with GD1. METHODS: Published on: Feb-2018 Read more
Clinical Efficacy of Percutaneous Transhepatic Portal Vein Angioplasty for Late-Onset Portal Vein Stenosis in Pediatric Liver Transplant Patients https://www.ncbi.nlm.nih.gov/pubmed/29470353 Liver transplantation Transplantation. 2018 Feb 20. doi: 10.1097/TP.0000000000002138. [Epub ahead of print] Naik KB, Hawkins CM, Gill AE, Gupta NA. Abstract BACKGROUND: Stenosis of the portal vein (PV) is a rare complication after liver transplantation (LT) in pediatric patients and it adversely affects outcomes. We reviewed the safety and efficacy of percutaneous transhepatic balloon angioplasty (PTBA) as a treatment for post-LT late-onset portal vein stenosis (PVS). METHODS: 318 patients between the ages of 0-21 years received a LT from 2001 to 2016 at this tertiary center. 21 children were evaluated for PVS using percutaneous portal venography. RESULTS: Published on: Feb-2018 Read more	Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with Gaucher disease. https://www.ncbi.nlm.nih.gov/pubmed/29471850 Gauchers Orphanet J Rare Dis. 2018 Feb 23;13(1):36. doi: 10.1186/s13023-018-0776-8. Zimran A, Wajnrajch M, Hernandez B, Pastores GM. Abstract Published on: Feb-2018 Read more

CLF Intro movie

SMS requests to

9224791366

Ask The Expert

Pediatric Liver Specialists in India

Centres offering Genetic Testing for Pediatric Liver Diseases

Financial Aid Offered by Trusts

Follow us on:

Facebook Twitter YouTube